An oral GLP-1 pill enters Phase 3, and the obesity race gets a new lane
DMDr. Dereck Mush, MD, MBA
Sep 4Biotech
The science companies behind the medicines: pipelines, platforms, trials and the moment a lab result becomes a therapy.
The HealthTech Signal
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
DMDr. Dereck Mush, MD, MBA
Jul 16The HealthTech Signal
A CDMO partnership shows how gene therapy manufacturing is scaling for chronic disease
A CDMO partnership shows how gene therapy manufacturing is scaling for chronic disease
DMDr. Dereck Mush, MD, MBA
Sep 3
CDMOs race to add capacity as cell and gene therapy demand outpaces supply
DMDr. Dereck Mush, MD, MBA
Jan 14
